Actively Recruiting
The SUITS Study: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Led by Erasmus Medical Center · Updated on 2026-05-27
220
Participants Needed
11
Research Sites
N/A
Total Duration
On this page
Sponsors
E
Erasmus Medical Center
Lead Sponsor
Z
Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the impact of replacing half of the outpatient clinic visits with home monitoring and video consultations for patients with pulmonary fibrosis. This study compares hospital-based care with a home monitoring program integrated into hospital care, aiming to assess effects on patient self-management and health outcomes over 12 months. Participants will be randomly assigned to either hospital-based care, which includes outpatient visits every three months with lung function tests, or a home monitoring program. The home monitoring group uses a mobile app with weekly home measurements such as spirometry, pulse oximetry, and patient-reported outcomes. Half of their outpatient visits are replaced by video consultations. The home program also provides a medication coach and disease-specific information. During the study, patients complete questionnaires at set times while researchers monitor lung function, health status, healthcare use, and patient adherence. Both groups undergo regular lung function testing and fill out assessment tools. The main outcome measured is patient self-management over 12 months. Safety and healthcare outcomes are tracked through hospital visits, emergency visits, and mortality or lung transplantation data.
CONDITIONS
Brief Title
Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with pulmonary fibrosis by a multidisciplinary ILD team according to ATS/ERS/JRS/ALAT guidelines
- Adults aged 18 years or older
You will not qualify if you...
- Unable to speak, read, or write Dutch
- No access to the internet
- Life expectancy less than 1 year as determined by the healthcare provider
- Current or previous use of a home monitoring program for pulmonary fibrosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 months
Participants receive either hospital-based care with outpatient clinic visits every three months including lung function testing, or home monitoring care involving weekly home measurements, patient-reported outcomes, and alternating remote video consultations with outpatient visits.
Outpatient clinic visits every 3 months; weekly home measurements for home monitoring group; alternating remote video consultations replacing half of outpatient visits for home monitoring group
Trial Site Locations
Total: 11 locations
1
Department of Pulmonology, Onze Lieve Vrouwe Gasthuis
Amsterdam, Netherlands
Actively Recruiting
2
Department of Pulmonary Diseases, Rijnstate Hospital
Arnhem, Netherlands
Actively Recruiting
3
Department of Respiratory Medicine, Amphia Hospital
Breda, Netherlands
Actively Recruiting
4
Department of Respiratory Medicine, Catharina Hospital
Eindhoven, Netherlands
Actively Recruiting
5
Department of Pulmonary Medicine, Zuyderland Medical Centre
Heerlen, Netherlands
Actively Recruiting
6
Department of Pulmonology, Medical Center Leeuwarden
Leeuwarden, Netherlands
Actively Recruiting
7
Department of Pulmonology, Leiden University Medical Center
Leiden, Netherlands
Actively Recruiting
8
Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital
Nieuwegein, Netherlands
Actively Recruiting
9
Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center
Rotterdam, Netherlands
Actively Recruiting
10
Department of Pulmonology, Haaglanden Medisch Centrum
The Hague, Netherlands
Actively Recruiting
11
Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University
Utrecht, Netherlands
Actively Recruiting
Research Team
D
Delian E. Hofman
C
Catharina C. Moor
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here